Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Acrocephalosyndactylia × infigratinib × Clear all

Phase

Phase 1 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 2 Cholangiocarcinoma 2 Squamous Cell Carcinoma of Head and Neck 1 Papillomavirus Infections 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Melanoma 1 Hematologic Neoplasms 1 Glioblastoma 1 Acrocephalosyndactylia 1

Interventions

pemigatinib 5 Rogaratinib 2 pembrolizumab 1 lenvatinib 1 infigratinib 1 erdafitinib 1 brivanib 1 Rabeprazole 1 Irinotecan 1 INCB 54828-101 1 Gemcitabine 1 E-3810 1 Drug Combinations 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05019794 2022-06-27

FGFR

LianBio LLC

Phase 2 Unknown

Gastrointestinal

Acrocephalosyndactylia, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡